Option Care Health Sees FY2024 Adjusted EBITDA Of $430M-$450M Versus Prior Guidance Of $425M-$450M
Portfolio Pulse from Benzinga Newsdesk
Option Care Health has updated its FY2024 Adjusted EBITDA guidance to $430M-$450M, a slight increase from the previous range of $425M-$450M.
April 23, 2024 | 11:06 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Option Care Health has raised the lower end of its FY2024 Adjusted EBITDA guidance, indicating a positive outlook.
Raising the lower end of the EBITDA guidance range suggests that Option Care Health is more confident in its financial performance, potentially leading to positive investor sentiment and a short-term increase in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100